Schnapp A, Harel M, Cayam-rand D, Cassuto H, Polyansky L, Aran A. A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ. Biomedicines 2022;10:1685. [DOI: 10.3390/biomedicines10071685][Cited by in Crossref: 1][Cited by in F6Publishing: 2][Article Influence: 1.0][Reference Citation Analysis]
Number
Citing Articles
1
de Camargo RW, de Novais Júnior LR, da Silva LM, Meneguzzo V, Daros GC, da Silva MG, de Bitencourt RM. Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: A literature review. Pharmacol Biochem Behav 2022;221:173492. [PMID: 36379443 DOI: 10.1016/j.pbb.2022.173492][Reference Citation Analysis]